Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. J.G.W. (Jos) Kosterink

Publications

Azithromycin as host-directed therapy for pulmonary tuberculosis - a randomized pilot trial

Vvax001, a Therapeutic Vaccine for Patients with HPV16-positive High-grade Cervical Intraepithelial Neoplasia: a Phase II Trial

Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease

Infliximab in paediatric inflammatory bowel disease: External evaluation of population pharmacokinetic models

Monoclonal antibody biosimilars for cancer treatment

Pharmacometabolomics may be the next stamp in the pharmacogenetic passport

Validation of a method for the determination of Aderamastat (FP-025) in K 2EDTA human plasma by LC-MS/MS

Capsules with Ileocolonic-Targeted Release of Vitamin B2, B3, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process

Pharmacokinetic Boosting of Kinase Inhibitors

Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I-Penicillins

Press/media

Besparingen door effectiever voorschrijven medicijnen

Campagne Wemos over medicijnprijzen lanceert Monopoly, de Medicijn Editie

Hoe een Gronings ziekenhuis het opneemt tegen big pharma

In het lab werkte de medicatie. Maar de echte wereld is geen lab

UMCG gaat strijd aan tegen geneesmiddelkaping door farmaceuten

Waarom pillen steeds beter werken (Dagblad van het Noorden)

Interview zorg instituut Nederland

Nog genoeg medicatie Covid-19, maar lange termijn is onzeker